<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): December 18, 2008</B>


<P style="font-size: 18pt" align="center"><B>INTEGRA LIFESCIENCES HOLDINGS
CORPORATION<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>0-26224</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>51-0317849</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>311 Enterprise
Drive<BR>
Plainsboro, NJ <BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>08536</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(609) 275-0500</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>Not
Applicable<BR>
</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>



<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.</B>

<P style="font-size: 10pt" align="left">On December&nbsp;18, 2008, Integra
LifeSciences Holdings Corporation (the &#8220;Company&#8221;) entered into
indemnification agreements with non-employee directors, executive officers and
the General Counsel.

<P style="font-size: 10pt" align="left">The form of Indemnification Agreement
for Non-Employee Directors and Officers is attached hereto as Exhibit&nbsp;10.1
and is incorporated herein by reference. In addition, the Company intends to
use this form if it enters into indemnification agreements in the future with
any non-employee directors or officers.

<P style="font-size: 10pt" align="left"><B>ITEM 5.02. DEPARTURE OF DIRECTORS OR
PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS;
COMPENSATION ARRANGEMENT OF CERTAIN OFFICERS.</B>

<P style="font-size: 10pt" align="left">(e)

<P style="font-size: 10pt" align="left"><B>AMENDMENT TO EMPLOYMENT AGREEMENTS
WITH CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER</B>

<P style="font-size: 10pt" align="left">On December&nbsp;18, 2008, the Company
and Gerard S. Carlozzi, the Company&#8217;s Executive Vice President and Chief
Operating Officer, entered into Amendment 2008-2 (the &#8220;Carlozzi
Amendment&#8221;) to Mr.&nbsp;Carlozzi&#8217;s Amended and Restated Employment
Agreement with the Company, dated as of December&nbsp;19, 2005 (the
&#8220;Carlozzi Employment Agreement&#8221;). In addition, on December&nbsp;18,
2008, the Company and John B. Henneman, III, the Company&#8217;s Executive Vice
President, Finance and Administration, and Chief Financial Officer, entered
into Amendment
2008-2 (the &#8220;Henneman Amendment&#8221;) to
Mr.&nbsp;Henneman&#8217;s Amended and Restated Employment Agreement with the
Company, dated as of December&nbsp;19, 2005 (the &#8220;Henneman Employment
Agreement&#8221;) (collectively, the Carlozzi Employment Agreement and the
Henneman Employment Agreement, the &#8220;Employment Agreements&#8221;). The
terms of the Carlozzi Amendment and the Henneman Amendment (collectively, the
&#8220;Amendments&#8221;) extend the term of each of Mr.&nbsp;Carlozzi&#8217;s
employment and Mr.&nbsp;Henneman&#8217;s employment until January&nbsp;4, 2011.

<P style="font-size: 10pt" align="left">In addition, the Amendments provide
that both Mr.&nbsp;Carlozzi and Mr.&nbsp;Henneman (collectively, the
&#8220;Executives&#8221;) will receive (i)&nbsp;a base salary of $475,000 for
2009 and $500,000 for 2010, (ii)&nbsp;an annual bonus opportunity for each of
2009 and 2010 equal to 50% of annual base salary and (iii)&nbsp;88,877
restricted stock units to be granted on December&nbsp;18, 2008, of which 83,846
units represent the signing equity-based award and 5,031 units represent the
equity-based award for 2008 performance. The restricted stock unit grants for
each Executive will, subject to the Executive&#8217;s continued service with
the Company, vest in two equal annual installments on the first two
anniversaries of the grant date and will be subject to accelerated vesting upon
the occurrence of any of the following: (i)&nbsp;termination of the
Executive&#8217;s employment by the Company without &#8220;Cause&#8221; or by
the Executive for &#8220;Good Reason,&#8221; (ii)&nbsp;a &#8220;Change in
Control&#8221; of the Company, (iii)&nbsp;a &#8220;Disability
Termination,&#8221; each as defined in the Employment Agreements, or
(iv)&nbsp;the Executive&#8217;s death. The shares underlying the units will be
paid out within the 30&nbsp;day period immediately following the six month
anniversary after the Executive&#8217;s separation from service with the
Company.

<P style="font-size: 10pt" align="left">The restricted stock unit grants will
include certain dividend equivalent rights.

<P style="font-size: 10pt" align="left">The foregoing description of the
Amendments is qualified in its entirety by reference to the copies of the
Amendments which are attached as Exhibit&nbsp;10.2 and Exhibit&nbsp;10.3 to
this Current Report on Form 8-K and are incorporated by reference herein. In
all other respects not amended, the Employment Agreements remain in full force
and effect.

<P style="font-size: 10pt" align="left"><B>PRESIDENT AND CHIEF EXECUTIVE
OFFICER BASE SALARY INCREASE AND BONUS MATTER</B>

<P style="font-size: 10pt" align="left">On December&nbsp;18, 2008, the
Compensation Committee of the Board of Directors of the Company increased the
annual base salary of Stuart Essig, the Company&#8217;s President and Chief
Executive Officer, from $600,000 to $650,000. The base salary increase will be
effective January&nbsp;1, 2009. At Mr.&nbsp;Essig&#8217;s request, the
Compensation Committee agreed not to award Mr.&nbsp;Essig a cash bonus for 2008.

<P style="font-size: 10pt" align="center">&nbsp;

<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>ITEM 9.01. FINANCIAL STATEMENTS AND
EXHIBITS.</B>

<P style="font-size: 10pt" align="left">(d)&nbsp;Exhibits.
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">Exhibit&nbsp;Number </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Description of Exhibit</TD>
 </TR>

 <TR style="font-size: 1px">
  <TD style="border-top: #000000 1px solid" valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD style="border-top: #000000 1px solid" valign="top" align="left">&nbsp;</TD>
 </TR>
<TR><TD>&nbsp;</TD></TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">10.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Form of Indemnification Agreement for
Non-Employee Directors and Officers</TD>
 </TR>
<TR><TD>&nbsp;</TD></TR>

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.2</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Amendment 2008-2, dated December&nbsp;18, 2008, to
Mr.&nbsp;Carlozzi&#8217;s Amended and Restated Employment Agreement between the
Company and Mr.&nbsp;Carlozzi</TD>
 </TR>

<TR><TD>&nbsp;</TD></TR>
 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.3</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Amendment 2008-2, dated December&nbsp;18, 2008, to
Mr.&nbsp;Henneman&#8217;s Amended and Restated Employment Agreement between the
Company and Mr.&nbsp;Henneman</TD>
 </TR>
<TR><TD>&nbsp;</TD></TR>
 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.4</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Form of Contract Stock/Restricted Units Agreement for Mr.&nbsp;Carlozzi
and Mr.&nbsp;Henneman</TD>
 </TR>

</TABLE>
</div>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt" align="left">Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, hereunto duly
authorized.

<P style="font-size: 10pt; margin-left: 55%" align="left"><FONT style="white-space: nowrap"><B>INTEGRA
LIFESCIENCES HOLDINGS CORPORATION</B></FONT>

<P style="font-size: 10pt" align="left">Date: December 24, 2008

<P style="margin-top: -11pt; font-size: 10pt; margin-left: 55%" align="left">By: <U>/s/ Stuart M. Essig</U><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart M. Essig<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President and Chief Executive Officer

<P style="font-size: 10pt" align="center">&nbsp;

<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">



<P style="font-size: 10pt" align="center"><B>Exhibit&nbsp;Index</B>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->
 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">Exhibit&nbsp;Number </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Description of Exhibit</TD>
 </TR>
 <TR style="font-size: 1px">
  <TD style="border-top: #000000 1px solid" valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD style="border-top: #000000 1px solid" valign="top"
align="left">&nbsp;</TD>
 </TR>
<TR><TD>&nbsp;</TD></TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">10.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Form of Indemnification Agreement for
Non-Employee Directors and Officers</TD>
 </TR>
<TR><TD>&nbsp;</TD></TR>

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.2</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Amendment 2008-2, dated December&nbsp;18, 2008, to
Mr.&nbsp;Carlozzi&#8217;s Amended and Restated Employment Agreement between the
Company and Mr.&nbsp;Carlozzi</TD>
 </TR>

<TR><TD>&nbsp;</TD></TR>
 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.3</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Amendment 2008-2, dated December&nbsp;18, 2008, to
Mr.&nbsp;Henneman&#8217;s Amended and Restated Employment Agreement between the
Company and Mr.&nbsp;Henneman</TD>
 </TR>
<TR><TD>&nbsp;</TD></TR>
 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.4</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Form of Contract Stock/Restricted Units Agreement for Mr.&nbsp;Carlozzi
and Mr.&nbsp;Henneman</TD>
 </TR>

</TABLE>
</DIV>


<P style="font-size: 10pt" align="center">&nbsp;

<P style="font-size: 10pt" align="center">&nbsp;
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c78646e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 15346}]
{"company-data": {"conformed-name": "INTEGRA LIFESCIENCES HOLDINGS CORP", "cik": "0000917520", "assigned-sic": "3826", "irs-number": "510317849", "state-of-incorporation": "DE", "fiscal-year-end": "1206"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26224", "film-number": "081270105"}, "business-address": {"street1": "311 C ENTERPRISE DRIVE", "city": "PLAINSBORO", "state": "NJ", "zip": "08536", "phone": "6092750500"}, "mail-address": {"street1": "311 C ENTERPRISE DRIVE", "city": "PLAINSBORO", "state": "NJ", "zip": "08536"}, "former-company": {"former-conformed-name": "INTEGRA LIFESCIENCES CORP", "date-changed": "19950614"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): December 18, 2008
INTEGRA LIFESCIENCES HOLDINGS
CORPORATION
(Exact name of registrant as
specified in its charter)
Delaware
0-26224
51-0317849
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
311 Enterprise
Drive
Plainsboro, NJ
08536
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(609) 275-0500
Not
Applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On December 18, 2008, Integra
LifeSciences Holdings Corporation (the "Company") entered into
indemnification agreements with non-employee directors, executive officers and
the General Counsel.
The form of Indemnification Agreement
for Non-Employee Directors and Officers is attached hereto as Exhibit 10.1
and is incorporated herein by reference. In addition, the Company intends to
use this form if it enters into indemnification agreements in the future with
any non-employee directors or officers.
ITEM 5.02. DEPARTURE OF DIRECTORS OR
PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS;
COMPENSATION ARRANGEMENT OF CERTAIN OFFICERS.
(e)
AMENDMENT TO EMPLOYMENT AGREEMENTS
WITH CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
On December 18, 2008, the Company
and Gerard S. Carlozzi, the Company's Executive Vice President and Chief
Operating Officer, entered into Amendment 2008-2 (the "Carlozzi
Amendment") to Mr. Carlozzi's Amended and Restated Employment
Agreement with the Company, dated as of December 19, 2005 (the
"Carlozzi Employment Agreement"). In addition, on December 18,
2008, the Company and John B. Henneman, III, the Company's Executive Vice
President, Finance and Administration, and Chief Financial Officer, entered
into Amendment
2008-2 (the "Henneman Amendment") to
Mr. Henneman's Amended and Restated Employment Agreement with the
Company, dated as of December 19, 2005 (the "Henneman Employment
Agreement") (collectively, the Carlozzi Employment Agreement and the
Henneman Employment Agreement, the "Employment Agreements"). The
terms of the Carlozzi Amendment and the Henneman Amendment (collectively, the
"Amendments") extend the term of each of Mr. Carlozzi's
employment and Mr. Henneman's employment until January 4, 2011.
In addition, the Amendments provide
that both Mr. Carlozzi and Mr. Henneman (collectively, the
"Executives") will receive (i) a base salary of $475,000 for
2009 and $500,000 for 2010, (ii) an annual bonus opportunity for each of
2009 and 2010 equal to 50% of annual base salary and (iii) 88,877
restricted stock units to be granted on December 18, 2008, of which 83,846
units represent the signing equity-based award and 5,031 units represent the
equity-based award for 2008 performance. The restricted stock unit grants for
each Executive will, subject to the Executive's continued service with
the Company, vest in two equal annual installments on the first two
anniversaries of the grant date and will be subject to accelerated vesting upon
the occurrence of any of the following: (i) termination of the
Executive's employment by the Company without "Cause" or by
the Executive for "Good Reason," (ii) a "Change in
Control" of the Company, (iii) a "Disability
Termination," each as defined in the Employment Agreements, or
(iv) the Executive's death. The shares underlying the units will be
paid out within the 30 day period immediately following the six month
anniversary after the Executive's separation from service with the
Company.
The restricted stock unit grants will
include certain dividend equivalent rights.
The foregoing description of the
Amendments is qualified in its entirety by reference to the copies of the
Amendments which are attached as Exhibit 10.2 and Exhibit 10.3 to
this Current Report on Form 8-K and are incorporated by reference herein. In
all other respects not amended, the Employment Agreements remain in full force
and effect.
PRESIDENT AND CHIEF EXECUTIVE
OFFICER BASE SALARY INCREASE AND BONUS MATTER
On December 18, 2008, the
Compensation Committee of the Board of Directors of the Company increased the
annual base salary of Stuart Essig, the Company's President and Chief
Executive Officer, from $600,000 to $650,000. The base salary increase will be
effective January 1, 2009. At Mr. Essig's request, the
Compensation Committee agreed not to award Mr. Essig a cash bonus for 2008.
ITEM 9.01. FINANCIAL STATEMENTS AND
EXHIBITS.
(d) Exhibits.
Exhibit Number
Description of Exhibit
10.1
Form of Indemnification Agreement for
Non-Employee Directors and Officers
10.2
Amendment 2008-2, dated December 18, 2008, to
Mr. Carlozzi's Amended and Restated Employment Agreement between the
Company and Mr. Carlozzi
10.3
Amendment 2008-2, dated December 18, 2008, to
Mr. Henneman's Amended and Restated Employment Agreement between the
Company and Mr. Henneman
10.4
Form of Contract Stock/Restricted Units Agreement for Mr. Carlozzi
and Mr. Henneman
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, hereunto duly
authorized.
INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
Date: December 24, 2008
By:
/s/ Stuart M. Essig
Stuart M. Essig
President and Chief Executive Officer
Exhibit Index
Exhibit Number
Description of Exhibit
10.1
Form of Indemnification Agreement for
Non-Employee Directors and Officers
10.2
Amendment 2008-2, dated December 18, 2008, to
Mr. Carlozzi's Amended and Restated Employment Agreement between the
Company and Mr. Carlozzi
10.3
Amendment 2008-2, dated December 18, 2008, to
Mr. Henneman's Amended and Restated Employment Agreement between the
Company and Mr. Henneman
10.4
Form of Contract Stock/Restricted Units Agreement for Mr. Carlozzi
and Mr. Henneman